Targetome

About Targetome

Targetome is aiming at solving unmet medical needs, such as pancreatic cancer or liver metastases using its proprietary biomarker discovery platform. Such diseases have a high mortality (95% after 5 years) due to the current lack of an efficient treatment and reliable diagnostics. Our proprietary platform has allowed for the selection of a new array of highly-specific novel therapeutics targets, for which we are developing a range of ADC (Antibody drug conjugates) able to target the tumor cells and deliver a toxic payload to the heart of the tumor. In parallel, Targetome is offering access to its platform to biotech, pharmaceuticals or diagnostic companies to help our partner to discover new biomarkers and therapeutic targets, and generate highly specific antibodies, against metabolic, inflammatory, oncology, CNS diseases,...

Website	http://www.targetome.be
Employees	11-50 employees View all Targetome employees
Industry	Biotechnology Research
Founded	2010
Keywords	Cancer, Biomarker Discovery, Targeted Therapies, Antibody Development